EUVIMEDEUVIMED entdecken
Crossref

Correction: Gene Expression Profiling to Predict Prognostic Biomarkers for Relapse in Multiple Myeloma

Editorial Office ALS

Advancements in Life Sciences · 04.07.2026 · 13

DOI: 10.62940/als.v13i0.4279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advancements in Life Sciences, online erschienen am 04.07.2026. Verfasst von Editorial Office ALS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This corrects "Elahi S, Fazal S. Gene Expression Profiling to Predict Prognostic Biomarkers for Relapse in Multiple Myeloma." Adv. Life Sci. 2024 May;11(2):329–337. doi: 10.62940/als.v11i2.1900.Following the publication of this article, an internal audit — conducted in response to quality concerns raised by Web of Science — identified problems in the use of references in the originally published version. The necessary corrections (formatting) to the bibliographic section (numbering sequence) have since been carried out, and the Editorial Expression of Concern issued on 18 May 2025 has accordingly been withdrawn. The earlier published copy of this article is available on request at als.editor@als-journal.com.The Advancements in Life Sciences Editorial Office regrets that these issues were not identified prior to publication.History of the correction processEditorial Expression of Concern18 May 2025: Following publication of this paper, the internal audit (consequent to concerns on quality raised by Web of Science) notified Advancements in Life Sciences about problems in use of references. By this Editorial Expression of Concern, we alert the scientific community as we address the errors.Correction Published29 May 2025: The necessary corrections have been carried out in the Version of Record. Expression of concern is hereby revoked.

Zitieren

APA

ALS, E. O. (2026). Correction: Gene Expression Profiling to Predict Prognostic Biomarkers for Relapse in Multiple Myeloma. Advancements in Life Sciences, 13. https://doi.org/10.62940/als.v13i0.4279

Vancouver

ALS EO. Correction: Gene Expression Profiling to Predict Prognostic Biomarkers for Relapse in Multiple Myeloma. Advancements in Life Sciences. 2026;13. doi:10.62940/als.v13i0.4279

BibTeX
@article{ALS2026,
  author = {ALS, Editorial Office},
  title = {Correction: Gene Expression Profiling to Predict Prognostic Biomarkers for Relapse in Multiple Myeloma},
  journal = {Advancements in Life Sciences},
  year = {2026},
  volume = {13},
  doi = {10.62940/als.v13i0.4279}
}
Kostenlos starten →